Cargando…
Erlotinib in a patient with vaginal carcinoma and pulmonary metastasis: A case report
Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor. It is widely used in the treatment of advanced non-small cell lung cancer and pancreatic cancer. However, there are currently no reports of the efficacy of erlotinib in patients with metastatic vaginal carcinoma. A 48-year-o...
Autores principales: | MA, QING, REN, YAO-YAO, LIU, XIA, GONG, TING, ZHONG, DIAN-SHENG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919878/ https://www.ncbi.nlm.nih.gov/pubmed/24527088 http://dx.doi.org/10.3892/ol.2014.1805 |
Ejemplares similares
-
Vaginal implantation metastasis of endometrial carcinoma: A case report
por: WANG, YUELING, et al.
Publicado: (2016) -
Increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis
por: Ma, Qing, et al.
Publicado: (2015) -
Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report
por: Ohara, Sayaka, et al.
Publicado: (2014) -
Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation
por: Liu, Jing, et al.
Publicado: (2016) -
Successful Use of Erlotinib in Treating Recurrent Thymic Carcinoma: A Case Report
por: Brown, Lisa A.
Publicado: (2013)